Google stock price forecast: Alphabet rises after Canaccord lifts target to $390

Google stock price forecast: Alphabet rises after Canaccord lifts target to $390

NEW YORK, January 7, 2026, 15:30 EST — Regular session Alphabet’s Class A shares rose 2.5% to $322.25 on Wednesday, near the day’s high, after Canaccord Genuity raised its price target for the Google parent. The stock hit an intraday high of $326.11 and was up $7.91 from Tuesday’s close. The move puts a new “Google stock price forecast” back…
Uber stock price forecast: Robotaxi debut, analyst targets and the next catalysts for UBER

Uber stock price forecast: Robotaxi debut, analyst targets and the next catalysts for UBER

New York, January 7, 2026, 15:28 EST — Regular session Uber Technologies shares rose 0.7% to $86.10 on Wednesday after Uber and partners Lucid and Nuro debuted a production-intent robotaxi at CES, the Consumer Electronics Show, in Las Vegas. Uber, which sold its self-driving unit to Aurora Innovation in 2020, has since leaned on partnerships to bring robotaxis onto its…
CoreWeave stock price forecast: Wall Street still sees $121 target after Nvidia Rubin news, but shares wobble

CoreWeave stock price forecast: Wall Street still sees $121 target after Nvidia Rubin news, but shares wobble

New York, Jan 7, 2026, 15:29 EST — Regular session CoreWeave shares were down about 0.6% at $77.51 in afternoon trading on Wednesday after swinging between $75.77 and $79.92. The CoreWeave stock price forecast looks messy: analyst targets tracked by Benzinga ranged from $36 to $180 over the past quarter, with an average of $121.48, down from $142.  Benzinga Why…
Costco stock price forecast: Wall Street’s $1,000 call meets a holiday-sales test after the bell

Costco stock price forecast: Wall Street’s $1,000 call meets a holiday-sales test after the bell

New York, January 7, 2026, 15:41 EST — Regular session Costco Wholesale Corp shares eased on Wednesday as traders braced for a December sales update due after the bell, a report that could reset near-term views on the stock. The shares were down 0.6% at $884.07 in afternoon trade. The timing matters. Costco’s monthly sales releases are one of the…
7 January 2026
Texas InstrumentsTexas Instruments stock slides 3.6% as chip rally cools; Jan. 27 earnings call in focus

Texas InstrumentsTexas Instruments stock slides 3.6% as chip rally cools; Jan. 27 earnings call in focus

NEW YORK, Jan 7, 2026, 15:30 ET — Regular session Texas Instruments Incorporated shares were down 3.6% at $185.23 in late afternoon trading on Wednesday, after closing at $192.10 a day earlier. NXP Semiconductors fell 3.1%, while Microchip Technology slid 2.0% and Analog Devices and ON Semiconductor each dipped about 0.4%. The pullback matters because Texas Instruments is widely watched…
Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

New York, Jan 7, 2026, 15:40 (EST) — Regular session Merck & Co (MRK.N) shares were down about 0.3% at $108.59 in afternoon trade on Wednesday after the drugmaker said it had completed its cash tender offer for Cidara Therapeutics (CDTX.O) and expected to finish the acquisition through a merger later in the day. The company said the deal will…
Oracle stock price forecast: Wall Street splits as UBS cuts to $280 and Jefferies sticks with $400

Oracle stock price forecast: Wall Street splits as UBS cuts to $280 and Jefferies sticks with $400

NEW YORK, January 7, 2026, 15:31 EST — Regular session Oracle shares were little changed on Wednesday as investors digested fresh analyst calls that painted a wide 12-month path for the stock. The shares were down 0.1% at $193.52 in mid-afternoon trade, after touching $195.49 earlier in the session. Why it matters now: Oracle has become a proxy for investor…
Intel stock price forecast: INTC jumps on 18A chip rollout as a $50 target re-enters view

Intel stock price forecast: INTC jumps on 18A chip rollout as a $50 target re-enters view

New York, January 7, 2026, 15:29 EST — Regular session Intel shares jumped 6.3% to $42.56 in afternoon trading on Wednesday, outpacing a slide in chip ETFs, as investors leaned into the company’s CES pitch that its new 18A manufacturing push is ready for prime time. The iShares Semiconductor ETF fell 1.2% and VanEck’s chip ETF slipped 0.7%, while the…
Meta stock price forecast: China review of Manus deal drags META as Wall Street targets $822

Meta stock price forecast: China review of Manus deal drags META as Wall Street targets $822

New York, January 7, 2026, 15:28 EST — Regular session Meta Platforms (META.O) shares fell about 1.7% to $649.66 on Wednesday afternoon after a report said Chinese officials are reviewing the company’s purchase of artificial intelligence startup Manus. The Financial Times said the review could hinge on whether the transaction required an export license under Chinese law; Meta and Manus…
Pentagon-Lockheed deal aims to triple PAC-3 Patriot interceptor output to 2,000 a year

Pentagon-Lockheed deal aims to triple PAC-3 Patriot interceptor output to 2,000 a year

PentagoWASHINGTON, January 7, 2026, 15:34 (EST) The U.S. Department of War said it has signed a seven-year framework agreement with Lockheed Martin to lift annual production of the PAC-3 Missile Segment Enhancement (MSE) — a Patriot interceptor meant to hit incoming missiles — to about 2,000 units from roughly 600. The department said it will also work with key suppliers…
PLTR stock price forecast: Palantir climbs as Truist slaps $223 target on shares

PLTR stock price forecast: Palantir climbs as Truist slaps $223 target on shares

NEW YORK, Jan 7, 2026, 15:34 EST — Regular session Palantir Technologies (PLTR) shares rose 1.8% to $182.98 in late afternoon trading on Wednesday after Truist Securities initiated coverage with a buy rating and a $223 price target. The stock ranged between $177.70 and $187.26, with traders eyeing whether it can stay north of $180 into the close.  Investing The…

Stock Market Today

  • Treace Medical Concepts (TMCI) Stock Shows 81% Upside Amid Profitability Concerns
    January 23, 2026, 8:12 AM EST. Treace Medical Concepts, Inc. (NASDAQ: TMCI) trades near its 52-week low at $2.69, despite a market cap of $171.4 million and a potential upside of 81% based on average analyst targets of $4.87. The healthcare device maker, known for its Lapiplasty 3D bunion correction system, shows 11.4% revenue growth but faces profitability challenges with a negative forward P/E of -3.96 and EPS of -0.80. Operational efficiency is weak, highlighted by a -51.63% return on equity and negative free cash flow of $9.2 million. Technical indicators reveal bearish momentum amid mixed analyst ratings, underscoring the stock's speculative nature. Investors should weigh growth prospects against financial risks carefully.
Go toTop